Paul M. Walker Sells 150,000 Shares of Spectral Medical Inc. (TSE:EDT) Stock

Spectral Medical Inc. (TSE:EDT) Director Paul M. Walker sold 150,000 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of C$0.65, for a total transaction of C$97,500.00.

Paul M. Walker also recently made the following trade(s):

• On Tuesday, July 16th, Paul M. Walker sold 100,000 shares of Spectral Medical stock. The shares were sold at an average price of C$0.49, for a total value of C$49,000.00.

Spectral Medical Trading Down 1.5 %

Shares of TSE EDT opened at C$0.66 on Wednesday. Spectral Medical Inc. has a 12-month low of C$0.30 and a 12-month high of C$0.75. The company has a market cap of C$185.63 million, a price-to-earnings ratio of -9.57 and a beta of 0.99. The company has a current ratio of 0.61, a quick ratio of 0.45 and a debt-to-equity ratio of 26.03. The stock’s 50 day simple moving average is C$0.60 and its 200 day simple moving average is C$0.52.

Spectral Medical (TSE:EDT) last announced its quarterly earnings results on Friday, August 9th. The company reported C($0.02) earnings per share (EPS) for the quarter. The firm had revenue of C$0.47 million for the quarter. Equities research analysts expect that Spectral Medical Inc. will post -0.05 EPS for the current year.

Spectral Medical Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.